Answers are grounded in this paper and cite their sources.
Laboratory study reveals that proteoglycan NG2 functions as a tumor-specific antigen in rat chondrosarcoma, indicating a defined target for immune recognition.
N-terminal sequences of 19 and 11 amino acids obtained from 2 different tryptic fragments of the tumour-specific antigen on the chemically induced rat chondrosarcoma HSN show a 100% homology with the rat chondroitin sulfate proteoglycan NG2. Using a scheme of overlapping oligonucleotide primers we have cloned by PCR amplification the cDNA for the specific antigen of the HSN tumour that is immunogenic in immunocompetent CBH/Cbi rats and now report that its cDNA sequence is identical to that of NG2. The cDNA codes for a transmembrane protein of 2,325 amino acids with a large extracellular domain of 2,224 amino acids containing 2 cysteine-rich regions, a transmembrane domain (25 amino acids) and a short cytoplasmic tail (76 amino acids). The tumour-specific determinant was found to lie between amino acid residues 556 and 992 on the core glycoprotein.
No takes yet. Share an insight, caveat, or question.
Léger et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: